In this study, we delve into the FOXA1/BMI1 axis within NPC, identifying a pivotal link between diminished FOXA1 expression and BMI1’s role in promoting malignancy and cisplatin resistance. This evidence concerns the gene BMI1 and nasopharyngeal carcinoma.